Related Experiment Video
Updated: Jun 26, 2025
Assessing Functional Performance in the Mdx Mouse Model
Published on: March 27, 2014
Dmd mdx mice have defective oligodendrogenesis, delayed myelin compaction and persistent hypomyelination
Andrea J Arreguin1,2, Zijian Shao1, Holly Colognato1
1Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY 11794, USA.
Abstract:
Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene, resulting in the loss of dystrophin, a large cytosolic protein that links the cytoskeleton to extracellular matrix receptors in skeletal muscle. Aside from progressive muscle damage, many patients with DMD also have neurological deficits of unknown etiology. To investigate potential mechanisms for DMD neurological deficits, we assessed postnatal oligodendrogenesis and myelination in the Dmdmdx mouse model. In the ventricular-subventricular zone (V-SVZ) stem cell niche, we found that oligodendrocyte progenitor cell (OPC) production was deficient, with reduced OPC densities and proliferation, despite a normal stem cell niche organization. In the Dmdmdx corpus callosum, a large white matter tract adjacent to the V-SVZ, we also observed reduced OPC proliferation and fewer oligodendrocytes. Transmission electron microscopy further revealed significantly thinner myelin, an increased number of abnormal myelin structures and delayed myelin compaction, with hypomyelination persisting into adulthood. Our findings reveal alterations in oligodendrocyte development and myelination that support the hypothesis that changes in diffusion tensor imaging seen in patients with DMD reflect developmental changes in myelin architecture.
Insights
Duchenne muscular dystrophy (DMD) causes neurological deficits by impairing oligodendrocyte development and myelination. This study in Dmdmdx mice reveals reduced oligodendrocyte progenitor cells and hypomyelination, impacting white matter development.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Duchenne muscular dystrophy (DMD) is a genetic disorder caused by mutations in the DMD gene, leading to dystrophin deficiency.
- Patients with DMD often exhibit neurological deficits, but the underlying mechanisms remain unclear.
- Oligodendrocytes are crucial for myelin sheath formation in the central nervous system.
Purpose of the Study:
- To investigate the impact of DMD on oligodendrogenesis and myelination in the brain.
- To explore potential mechanisms contributing to neurological deficits in DMD patients.
Main Methods:
- Utilized the Dmdmdx mouse model, a common model for DMD.
- Assessed oligodendrocyte progenitor cell (OPC) production and proliferation in the ventricular-subventricular zone (V-SVZ).
- Examined myelination in the corpus callosum using transmission electron microscopy.
Main Results:
- Reduced OPC production and proliferation were observed in the V-SVZ of Dmdmdx mice.
- Fewer oligodendrocytes and decreased OPC proliferation were found in the corpus callosum.
- Significant hypomyelination, including thinner myelin and abnormal structures, persisted into adulthood.
Conclusions:
- DMD affects oligodendrocyte development and myelination, contributing to neurological deficits.
- Findings support the hypothesis that altered myelin architecture underlies diffusion tensor imaging changes in DMD patients.
